Imalux closes $5.1m series C:
This article was originally published in Clinica
Imalux, a Cleveland, Ohio company developing an imaging system based on optical coherence tomography, has raised $5.1m in an oversubscribed series C round. The funds, which included $2.5m of bridge financing, came from lead investors Early Stage Partners, ElectroSonics Medical, Reservoir Venture Partners and Symark, as well as over 20 existing and new investors. Imalux said it will use the proceeds to add a further 10-20 units of its Niris imaging system in the US and Europe for clinical validation (there are already over 20 systems installed worldwide), and to support multi-centre studies of the system on bladder cancer patients. The Niris system uses near-infrared light to create real-time images that reveal changes in the stratified structure of tissue.